Compounds > vindesine
Page last updated: 2024-08-23

vindesine and Infection

vindesine has been researched along with Infection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frey, N; Goldstein, S; Hexner, EO; Landsburg, DJ; Loren, A; Luger, S; Nasta, SD; Perl, AE; Porter, DL; Stadtmauer, E; Tsai, DE1
Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P1
Bastion, Y; Bosly, A; Coiffier, B; Dabouz-Harrouche, F; Deconinck, E; Dupriez, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Marit, G; Marolleau, JP; Reyes, F; Tilly, H; Yver, A1
Anselmi, A; Carella, AM; Carlier, P; Cimino, G; Congiu, A; Mangoni, L; Mazza, P; Meloni, G; Porcellini, A1

Trials

4 trial(s) available for vindesine and Infection

ArticleYear
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
    American journal of hematology, 2013, Volume: 88, Issue:8

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cisplatin; Cyclophosphamide; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Incidence; Infections; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Vincristine; Vindesine

2013
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
    American journal of hematology, 2014, Volume: 89, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine

2014
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lenograstim; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Placebos; Recombinant Proteins; Survival Rate; Treatment Outcome; Vindesine

1997
Italian experience with autologous bone marrow transplantation in 104 advanced Hodgkin's lymphoma patients.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Clinical Trials as Topic; Hodgkin Disease; Humans; Infections; Transplantation, Autologous; Vindesine

1989